Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | NBTB | HGV |
|---|---|---|
| Price | $50.95 | $34.05 |
| Change today | ▼ 1.13% | ▼ 2.32% |
| Market cap | $2.65B | $2.65B |
| Return, 3 months | +3.5% | -33.5% |
| Return, year to date | +25.8% | -23.9% |
| Return, 1 year | +26.2% | -22.3% |
| P/E (TTM) | 12.4 | 19.3 |
| P/B | 1.4 | 2.4 |
| P/E percentile vs own 5y | 41st | 50th |
| Dividend yield | 2.90% | – |
| Revenue growth (YoY, latest qtr) | +20.9% | – |
| Net profit growth (YoY) | +20.3% | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | 24.4% | – |
| Return on equity | – | – |
| Analyst target vs. price | +9.9% | +68.9% |
| Analyst buy share | 50% | 29% |
| RSI (14) | 48 | 24 |
| 30-day volatility | 15.3% | 26.6% |
| Max drawdown, 1 year | -12.2% | -37.7% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.